Lipocine Inc

Lipocine Inc is a clinical-stage biopharmaceutical company based in Salt Lake City, UT, specializing in innovative drug delivery technologies aimed at improving patient compliance and absorption for metabolic and endocrine disorders. Their progressive pipeline includes FDA-approved therapies and proprietary candidates for conditions such as low testosterone, obesity management, postpartum depression, and non-alcoholic steatohepatitis (NASH).

The company leverages its pioneering Lipral technology to enhance the oral absorption of water-insoluble drugs, facilitating the repositioning of established therapies through an efficient regulatory pathway. With a focus on conditions like liver disease and recurrent preterm birth, Lipocine is committed to advancing health outcomes through effective oral delivery solutions.

Generated from the website